An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions

CompletedOBSERVATIONAL
Enrollment

39,624

Participants

Timeline

Start Date

November 20, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions
Metastatic Pancreatic CancerLiver MetastasesGadoxetate Sodium-enhanced Magnetic Resonance Imaging
Interventions
PROCEDURE

EOB-MRI

Retrospective analysis for pancreatic cancer patients who had a record of EOB-MRI in the Medical Data Vision (MDV) database in Japan

PROCEDURE

Surgery

Retrospective analysis for pancreatic cancer patients who had a record of any surgery for the pancreatic cancer in the Medical Data Vision (MDV) database in Japan

PROCEDURE

Open-close Laparotomy

Retrospective analysis for pancreatic cancer patients who had a record of an open-close laparotomy in the Medical Data Vision (MDV) database in Japan

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY

NCT06106568 - An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions | Biotech Hunter | Biotech Hunter